Comparative risk of major bleeding with new oral anticoagulants (NOACs) and phenprocoumon in patients with atrial fibrillation: a post-marketing surveillance study

Artigo Revisado por pares

2017; Springer Science+Business Media; Volume: 106; Issue: 8 Linguagem: Inglês

10.1007/s00392-017-1098-x

ISSN

1861-0692

Autores

Stefan H. Hohnloser, Edin Basic, Michael Näbauer,

Tópico(s)

Venous Thromboembolism Diagnosis and Management

Ver no editor

Altmetric

PlumX